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Endothelial dysfunction is recognized as an in-
dependent risk factor for the development of 
cardiovascular diseases, and is characterized by 
a reduced bioavailability of the antithrombotic 
and antiatherosclerotic autacoid NO (Davignon 
and Ganz, 2004). The decrease in NO is directly 
related to increased vascular oxidative stress, as 
O2
 readily reacts with NO to form peroxyni-
trite. Perhaps more importantly, the oxidative 
depletion  of  tetrahydrobiopterin  causes  the 
so-called uncoupling of endothelial NO syn-
thase (eNOS), leading to the production of O2
 
instead of NO by the enzyme (Schulz et al., 
2008). Despite the undisputed role of oxidative 
stress in the etiology of endothelial dysfunc-
tion, large clinical trials with antioxidant ther-
apies have failed to show a beneficial effect on 
cardiovascular outcome (Thomson et al., 2007). 
This discrepancy is probably explained at least 
in part by the formation of other reactive oxy-
gen species from O2
 that have more complex 
roles  in  intracellular  signaling  beyond  NO 
scavenging. Several superoxide dismutases con-
vert O2
 to the more stable H2O2 that has 
widespread  and  more  prolonged  effects  on 
endothelial cell function (for review see Cai, 
2005). H2O2 is in turn eliminated through the 
actions of catalase and peroxidases. However, 
it is important to note that the exogenous ap-
plication of catalase can ameliorate endothelial 
dysfunction in some models of hypertension 
(Ulker et al., 2003), whereas catalase aggra-
vates the situation in models characterized by 
the uncoupling of eNOS (Landmesser et al., 
2003). To date, several studies have reported that 
promoting the conversion of O2
 to H2O2 to 
relieve NO scavenging does not prevent the 
CORRESPONDENCE  
Annemarieke Loot:  
Loot@vrc.uni-frankfurt.de
Abbreviations used: ACh, acetyl-
choline; Ang  II,  angiotensin  II; 
DN, dominant negative; eNOS, 
endothelial  NO  synthase;  PEG, 
polyethylene glycol; PYK2, pro-
line-rich tyrosine kinase 2.
Angiotensin II impairs endothelial  
function via tyrosine phosphorylation  
of the endothelial nitric oxide synthase
Annemarieke E. Loot,1 Judith G. Schreiber,2 Beate Fisslthaler,1  
and Ingrid Fleming1
1Institute for Vascular Signaling, Center for Molecular Medicine and 2Institute for Cardiovascular Physiology,  
Johann Wolfgang Goethe University, 60590 Frankfurt am Main, Germany
Proline-rich tyrosine kinase 2 (PYK2) can be activated by angiotensin II (Ang II) and reac-
tive oxygen species. We report that in endothelial cells, Ang II enhances the tyrosine 
phosphorylation of endothelial NO synthase (eNOS) in an AT1-, H2O2-, and PYK2-depen-
dent manner. Low concentrations (1–100 µmol/liter) of H2O2 stimulated the phosphoryla-
tion of eNOS Tyr657 without affecting that of Ser1177, and attenuated basal and 
agonist-induced NO production. In isolated mouse aortae, 30 µmol/liter H2O2 induced 
phosphorylation of eNOS on Tyr657 and impaired acetylcholine-induced relaxation. Endo-
thelial overexpression of a dominant-negative PYK2 mutant protected against H2O2-
induced endothelial dysfunction. Correspondingly, carotid arteries from eNOS/ mice 
overexpressing the nonphosphorylatable eNOS Y657F mutant were also protected against 
H2O2. In vivo, 3 wk of treatment with Ang II considerably increased levels of Tyr657-
phosphorylated eNOS in the aortae of wild-type but not Nox2y/ mice, and this was again 
associated with a clear impairment in endothelium-dependent vasodilatation in the wild-
type but not in the Nox2y/ mice. Collectively, endothelial PYK2 activation by Ang II and 
H2O2 causes the phosphorylation of eNOS on Tyr657, attenuating NO production and 
endothelium-dependent vasodilatation. This mechanism may contribute to the endothelial 
dysfunction observed in cardiovascular diseases associated with increased activity of the 
renin–angiotensin system and elevated redox stress.
© 2009 Loot et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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Mouse lung endothelial cells, which maintain respon-
siveness to Ang II in culture, were used to analyze the path-
way leading to eNOS Tyr657 phosphorylation by Ang II. As 
was the case with the native porcine endothelial cells, 100 
nmol/liter Ang II induced the phosphorylation of eNOS on 
Tyr657, and this was directly dependent on PYK2 activation 
because Ang II failed to increase eNOS phosphorylation in 
endothelial cells pretreated with PYK2 siRNA (Fig. 2 A). 
Furthermore, the activation of PYK2 by Ang II was pre-
vented by 10 µmol/liter telmisartan (Fig. 2 B), demonstrating 
the involvement of the AT1 receptor. Ang II–induced H2O2 
production seems to underlie the activation of PYK2, as the 
addition of Ang II to mouse lung endothelial cells resulted in 
the production of H2O2 (Fig. S1), and 150 U/ml polyethyl-
ene glycol (PEG)–catalase prevented the Ang II–induced 
phosphorylation of PYK2 as well as the subsequent phos-
phorylation of eNOS (Fig. 2, C and D). Collectively, these 
data indicate that Ang II induces eNOS Tyr657 phosphor-
ylation through an AT1 receptor–, H2O2-, and PYK2-
dependent mechanism.
Incubation of cultured human endothelial cells with 
H2O2 for 5 min also elicited the tyrosine phosphorylation of 
eNOS. The latter response was detectable at concentrations 
as low as 100 nmol/liter (Fig. 3 A). At high concentrations 
(300–500 µmol/liter), however, H2O2 stimulates the influx 
of Ca2+ into endothelial cells (Edwards et al., 2008), and this 
was associated with the phosphorylation of eNOS on Ser1177 
(Fig. 3 A). This dual effect on eNOS phosphorylation was 
also reflected by changes in eNOS activity. At low concen-
trations (e.g., 30 µmol/liter), H2O2 inhibited basal eNOS 
activity, whereas high concentrations (300–500 µmol/liter) 
stimulated NO production (Fig. 3 B). The latter phenome-
non has also been reported by other authors (Thomas et al., 
formation of atherosclerotic lesions and that superoxide dis-
mutase activity actually correlates with lesion size (Tribble 
et al., 1997; Zanetti et al., 2001). These observations suggest 
that the impairment of eNOS activity by oxidative stress is 
more complex than hitherto assumed.
We recently reported that Tyr657 in the reductase do-
main of eNOS is a critical determinant of enzymatic activity. 
For example, the phosphorylation of Tyr657 by proline-rich 
tyrosine kinase 2 (PYK2) decreases eNOS activity, and the 
mutation of Tyr657 to a phosphomimetic glutamate or aspar-
tate residue completely abolished NO production (Fisslthaler 
et al., 2008). PYK2 is generally considered to be a redox-sen-
sitive kinase that is activated after stimulation with angiotensin 
II (Ang II) as well as in other situations associated with ele-
vated oxidative stress (Tai et al., 2002; Yin et al., 2003). As el-
evated Ang II levels and increased oxidative stress are hallmarks 
of most cardiovascular diseases and associated with impaired 
endothelial function, we hypothesized that direct inactivation 
of eNOS via its tyrosine phosphorylation by PYK2 contrib-
utes to the phenomenon of endothelial dysfunction.
RESULTS AND DISCUSSION
Ang II and H2O2 induce activation of endothelial PYK2  
and phosphorylation of eNOS on Tyr657,  
and decrease eNOS activity
In native porcine aortic endothelial cells, 1 µmol/liter Ang II 
elicited  the  time-dependent  tyrosine  phosphorylation  of 
PYK2 (Fig. 1 A), which correlates with the activation of the 
kinase (Blaukat et al., 1999). The exogenous application of 
500 µmol/liter H2O2 also resulted in PYK2 phosphorylation 
(Fig. 1 A). Moreover, the activation of PYK2 by Ang II and 
H2O2 was mirrored by a pronounced increase in the phos-
phorylation of eNOS on Tyr657 (Fig. 1 B).
Figure 1.  Ang II and H2O2 activate PYK2 and phosphorylate eNOS on Tyr657. (A and B) Porcine aortae were incubated with solvent (Sol), 1 µmol/
liter Ang II, or 500 µmol/liter H2O2. The endothelial cells were isolated, and the tyrosine phosphorylation of PYK2 (A) and the phosphorylation of eNOS on 
Tyr657 (B) were assessed by immunoprecipitation (IP) followed by Western blotting (WB). The graphs summarize data from six samples from three inde-
pendent experiments. Data are expressed as means ± SEM. *, P < 0.05 versus solvent.JEM VOL. 206, December 21, 2009  2891
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dependent relaxation to acetylcholine (ACh; Fig. 4 B). To 
the best of our knowledge, the present investigation is the 
first to assess NO production in response to such a large range 
of H2O2 concentrations and to correlate these changes with 
the activity as well as the phosphorylation of eNOS on more 
than one regulatory site.
The impairment of NO-mediated vasodilatation  
by H2O2 is PYK2 dependent
It is clear that H2O2 can potentially affect the eNOS/cyclic 
GMP signaling cascade and subsequent vasodilatation at sev-
eral different levels. In addition to stimulating the phosphor-
ylation of eNOS, H2O2 can alter the activity of the soluble 
2002; Dossumbekova et al., 2008). To circumvent this con-
founding effect in further experiments, we concentrated on 
determining the responses to a maximum H2O2 concentra-
tion of 30 µmol/liter. At this low and potentially physio-
logically  more  relevant  concentration,  H2O2  significantly 
attenuated the activation of eNOS by bradykinin and iono-
mycin (Fig. 3 C). Furthermore, incubation of freshly isolated 
endothelium-intact mouse aortae with 30 µmol/liter H2O2 
for 10 min induced the phosphorylation of eNOS on Tyr657 
(Fig. 4 A). This concentration of H2O2 elicited only a small 
nonsignificant (10.7 ± 5.8%; n = 7; P = 0.068) decrease of 
vascular tone (which was corrected for by using the new pla-
teau as a baseline) and significantly impaired endothelium-
Figure 2.  Ang II phosphorylates eNOS on Tyr657 by activation of AT1, H2O2, and PYK2. (A) Mouse lung endothelial cells were transfected with a 
scrambled (CTL) siRNA or siRNA directed against PYK2 48 h before incubation with 100 nmol/liter Ang II. Thereafter, eNOS phosphorylated on Tyr657 was 
immunoprecipitated (IP) and detected by Western blotting (WB). Nonadjacent lanes from the same membrane and exposition are shown. (B) Effect of 100 
nmol/liter Ang II for 30 min, Ang II and 10 µmol/liter telmisartan (Telmi), or 30 µmol/liter H2O2 for 5 min on the tyrosine phosphorylation of PYK2. (C and D) 
Mouse lung homogenates were incubated with 150 U/ml PEG-catalase (Cat) for 1 h before stimulation with 100 nmol/liter Ang II for 20 min. The tyrosine 
phosphorylation of PYK2 (C) and eNOS (D) were assessed by immunoprecipitation and Western blotting. The graphs summarize data from six samples from 
three to six independent experiments. Data are expressed as means ± SEM. *, P < 0.05; and **, P < 0.01 versus the corresponding solvent (Sol) control.2892 eNOS phosphorylation in endothelial dysfunction | Loot et al.
completely protected the arteries against the effect of exoge-
nous H2O2 (Fig. 5 B). Such findings indicate that PYK2 ac-
tivation may underlie both the basal reduction in vascular 
responsiveness as well as the acute impairment of endothelial 
function elicited by the exogenous application of H2O2.
To demonstrate a causal relation between the phosphor-
ylation of eNOS on Tyr657 and impaired endothelial func-
tion,  experiments  were  repeated  in  carotid  arteries  from 
eNOS/ mice overexpressing either the wild-type eNOS 
or a nonphosphorylatable Y657F (tyrosine replaced by phe-
nylalanine) eNOS mutant. Consistent with the endogenous 
H2O2 production in eNOS/ carotid arteries after organ 
culture (Fig. S2 bottom), vessels transduced with wild-type 
eNOS relaxed to a maximum of only 50 ± 4%. The appli-
cation of H2O2, however, further decreased endothelium-
dependent relaxation in response to ACh (Fig. 5 C). In 
carotid arteries expressing similar levels of the Y657F eNOS 
mutant, relaxations to ACh were significantly improved 
under basal conditions (maximum relaxation = 79 ± 6%) 
and completely unaffected by exogenous H2O2 (Fig. 5 D). 
As organ culture enhanced endogenous H2O2 production 
in vessels from wild-type and eNOS/ mice alike, it seems 
that the oxidant is generated by vascular sources other than 
guanylyl cyclase (Meurer et al., 2005), as well as of several 
other tyrosine kinases and tyrosine phosphatases. To relate 
the decreased endothelium-dependent relaxation to the ac-
tivation of PYK2, responses to ACh were compared in ca-
rotid arteries from wild-type mice in which the endothelial 
layer was infected with adenoviruses to overexpress either 
GFP or a dominant-negative (DN) PYK2. Although endo-
thelial infection followed by organ culture is a simple method 
and allows the transduction of many proteins of interest, 
including “rescue” experiments in tissues from knockout 
mice, it is not free of complications. Indeed, we observed 
that the maintenance of carotid arteries in culture for 48 h 
led to a significant increase in the endogenous production of 
H2O2 that was not affected by the expression of GFP or DN 
PYK2 (Fig. S2 top). Correspondingly, responses to ACh in 
solvent-treated  arteries  expressing  GFP  were  moderately 
impaired (maximal response = 68 ± 7%; Fig. 5 A; in com-
parison, freshly isolated wild-type arteries typically relax to 
90%; Fig. 4 B). However, the exogenous application of 
30 µmol/liter H2O2 further impaired endothelium-dependent 
relaxations (Fig. 5 A). Overexpression of the DN PYK2 
mutant significantly improved ACh-stimulated responses in 
solvent-treated arteries (maximal response = 83 ± 4%) and 
Figure 3.  H2O2 has a dual effect on eNOS phosphorylation and activity. (A–C) Human endothelial cells were incubated with 0.1–500 µmol/liter 
H2O2 for 15 min. Thereafter, either (A) eNOS was immunoprecipitated (IP) and its phosphorylation on Tyr657 and Ser1177 were detected by Western blot-
ting (IB), or (B and C) cyclic GMP levels were assessed by radioimmunoassay under basal conditions (B) or after stimulation with 1 µmol/liter bradykinin 
(BK) for 2 min or 100 nmol/liter ionomycin (iono) for 2 min (C). Some experiments were also performed in the presence of 300 µmol/liter Nnitro–L-argi-
nine (L-NA) for 60 min. The graphs summarize data from 8–12 experiments. Data are expressed as means ± SEM. *, P < 0.05; **, P < 0.01; and ***, P < 
0.001 versus CTL or the corresponding solvent (Sol)-treated group. §§§, P < 0.001 versus solvent for Ser1177 phosphorylation.JEM VOL. 206, December 21, 2009  2893
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cells (Dixit et al., 2005). However, as the reported IC50 value 
for the H2O2-induced inactivation of SHP-2 is 75 µmol/liter, 
it seems unlikely that SHP-2 inactivation is the main mecha-
nism by which H2O2 influences eNOS activity. At this stage, 
we cannot exclude the involvement of an additional phos-
phatase because H2O2 can result in the oxidation of the criti-
cal cysteine residues and, thus, inactivate a series of tyrosine 
phosphatases (Thomas et al., 2008). However, as the expres-
sion of DN PYK2 was sufficient to abrogate the H2O2-
induced endothelial dysfunction, we speculate that kinase 
activation is the predominant mechanism underlying the 
effects described.
Chronic treatment with Ang II stimulates the phosphorylation 
of eNOS on Tyr657 and endothelial dysfunction
Our results indicated that the phosphorylation of eNOS on 
Tyr657 is acutely related to a decrease in endothelial function, 
but the pathophysiological consequences of endothelial dys-
function  (e.g.,  atherosclerosis)  generally  develop  over  pro-
longed periods. To determine the physiological relevance of 
the mechanism described, we assessed eNOS phosphorylation 
in aortae from mice treated with Ang II over 3 wk, a proce-
dure previously shown to induce hypertension and vascular 
oxidative stress as well as endothelial dysfunction (Jung et al., 
2005). In segments of aortae isolated from wild-type mice 
treated with 1 mg/kg/day Ang II for 3 wk, a clear impairment 
in endothelial function was observed (Fig. 6 A). Although 
eNOS  expression  was  unaltered  by  the  Ang  II  treatment, 
eNOS Tyr657 phosphorylation was significantly higher in the 
Ang II–treated group (Fig. 6 B).
Many of the consequences of Ang II exposure are related 
to the formation of reactive oxygen species, such as H2O2, as a 
consequence of the activation of NADPH oxidases (for review 
see Garrido and Griendling, 2009). In endothelial cells, Ang II 
activates mainly the Nox2 (gp91phox) and Nox4 subunits, and 
the genetic disruption of Nox2 prevents the endothelial dys-
function observed in a high-renin model of hypertension (Jung 
et al., 2004). We therefore assessed eNOS phosphorylation in 
mice lacking the Nox2 subunit. Because the gene encoding 
Nox2 is located on the X chromosome, we compared male 
Nox2-deficient (Nox2y/) mice to their wild-type (Nox2y/+) 
counterparts. We found that the treatment of Nox2y/ mice 
with Ang II did not result in the attenuation of endothelium-
dependent responses to ACh (Fig. 6 C) and did not increase 
eNOS phosphorylation on Tyr657 (Fig. 6 D).
Endothelium-derived NO is not only essential for control-
ling vascular tone but is also a critical determinant for vascular 
gene expression, the recruitment of circulating cells, and the 
progression of vascular diseases such as atherosclerosis and reste-
nosis (Davignon and Ganz, 2004). Correspondingly, eNOS 
gene transfer is considered an attractive therapeutic option to 
improve endothelial function. However, although the exoge-
nous expression of eNOS successfully prevented smooth muscle 
cell migration in vitro (Largiadèr et al., 2008), a similar approach 
in human atherosclerotic lesions failed because the heterolo-
gously expressed eNOS was inactive (Tanner et al., 2007). 
eNOS. Whatever the mechanism responsible, we observed 
that DN PYK2 was able to protect vessels against H2O2- 
induced endothelial dysfunction as well as against the atten-
uated responsiveness to ACh that was associated with organ 
culture itself. As mutation of Tyr657 to the nonphosphory-
latable  phenylalanine  conferred  protection,  it  seems  that 
phosphorylation rather than the uncoupling of eNOS ac-
counts for the effects observed.
In addition to its effects on PYK2, H2O2 is reported to 
inactivate the protein tyrosine phosphatase SHP-2 (Tang   
et al., 2005). SHP-2 is of potential relevance to the current 
study because it is reported to deactivate PYK2 (Chauhan 
et al., 2000), and we have previously demonstrated that eNOS 
and SHP-2 can be coprecipitated from cultured endothelial 
Figure 4.  H2O2 induces Tyr657 phosphorylation and impairs endo-
thelium-dependent vasodilatation in isolated mouse aorta. (A) Iso-
lated aortae were incubated in the absence (Sol) or presence of 500 
µmol/liter H2O2 for 10 min, and phosphorylation of the immunoprecipi-
tated (IP) eNOS on Tyr657 was detected by Western blotting (WB). 
(B) ACh-induced vasodilatation was assessed in the absence (Sol) or 
presence of 30 µmol/liter H2O2 in aortic ring segments in the continuous 
presence of 10 µmol/liter diclofenac. The graphs summarize the results 
obtained in 4–10 different experiments. Data are expressed as means ± 
SEM. *, P < 0.05; and **, P < 0.01 versus CTL.2894 eNOS phosphorylation in endothelial dysfunction | Loot et al.
(Fleming et al., 2005). In some experiments, cyclic GMP production 
was assessed with a specific radioimmunoassay (GE Healthcare), as previ-
ously described (Fisslthaler et al., 2008). To silence PYK2 gene expres-
sion, mouse lung endothelial cells were transfected with a mixture of 
siRNA  duplexes  (5-AUCUGAGGCAGGCUGUUCCUCUUCU-3,   
5-UUUCGUUCCAGGUAGUGUCCCAGCU-3, and 5-UUCUCCA-
GCACUCCGAUGACAUCCU-3; Invitrogen) or with control oligonu-
cleotides of medium GC content (Eurogentec).
Porcine  aortae  collected  at  the  local  slaughterhouse  were  cut  open 
lengthwise, fixed in stainless steel frames containing Hepes-Tyrode solution, 
and incubated at 37°C for a total of 1 h. 1 µmol/liter Ang II was added 10 
or 30 min before, and 500 µmol/liter H2O2 was added 5 min before the end 
of the incubation period. Endothelial cells were recovered by scraping and 
centrifugation for 4 min at 4,000 rpm and 4°C.
Freshly isolated mouse lungs were cut into 1-mm3 pieces, suspended 
in modified Tyrode’s solution containing 100 µmol/liter l-arginine, and 
equilibrated for 2 h in a normal CO2 incubator. 150 U/ml PEG-catalase 
was added as indicated in the figures for 1 h before stimulation with   
100 nmol/liter Ang II for 15 min.
Immunoprecipitation and immunoblotting. Cells, isolated aortae, and 
lungs were lysed in Triton X-100 buffer. eNOS, tyrosine-phosphorylated 
proteins, or PYK2 were immunopreciptated with the appropriate antibodies. 
Detergent-soluble proteins or immunoprecipitates were heated with SDS-
PAGE sample buffer and separated by SDS-PAGE, and specific proteins were 
detected by immunoblotting as previously described (Fleming et al., 2005).
In the latter study, the supplementation of samples with essential 
cofactors, including tetrahydrobiopterin and L-arginine, failed 
to stimulate NO production, indicating that mechanisms other 
than enzyme uncoupling determine NO production in athero-
sclerotic lesions. It is tempting to speculate that the inactivation 
of eNOS as a consequence of its phosphorylation by PYK2 may 
play an important role; certainly in the setting of atherosclerosis, 
PYK2 may be sufficiently activated to influence eNOS. There-
fore, it follows that the expression of the nonphosphorylatable 
eNOS Y657F mutant could represent a more successful thera-
peutic approach.
MATERIALS AND METHODS
Materials. The mono-/polyclonal eNOS antibodies were from Santa Cruz 
Biotechnology, Inc.; the specific phospho-Tyr657 eNOS antibody was gen-
erated as previously described (Fisslthaler et al., 2008) by Eurogentec; and 
the anti-PYK2 antibody was from BD. Tyrosine-phosphorylated proteins 
were detected with a mixture of four antibodies: P-Tyr-100 (Cell Signaling 
Technology), Py20 (Santa Cruz Biotechnology, Inc.), Py20 (BD), and clone 
4G10 (Millipore). All other substances were obtained from Sigma-Aldrich.
Cell culture. The use of human umbilical vein endothelial cells was ap-
proved by the ethics committee of the Johann Wolfgang Goethe Univer-
sity medical faculty. Human umbilical vein endothelial cells and mouse 
lung endothelial cells were isolated and cultured as previously described 
Figure 5.  H2O2-induced endothelial dysfunction involves PYK2 and eNOS phosphorylation on Tyr657. (A–D) ACh-induced vasodilatation was 
assessed in the absence or presence of 30 µmol/liter H2O2 in carotid arteries from wild-type (A and B) or eNOS/ (C and D) mice infected with adenovi-
ruses to express GFP (A), a DN PYK2 mutant (B), wild-type eNOS (WT; C), or the Y657F eNOS mutant (YF; D). The inset shows expression of adenovirally 
delivered wild-type and Y657F eNOS. The graphs summarize the results obtained in six to eight different experiments. Data are expressed as means ± SEM. 
*, P < 0.05 versus the appropriate solvent control.JEM VOL. 206, December 21, 2009  2895
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3-mm aortic or carotid artery rings were connected to isometric force 
transducers at a resting force of 1 or 0.5 g, respectively, for standard organ 
chamber experiments. Relaxations to cumulatively increasing concentra-
tions of ACh were recorded in vessels preconstricted to 80% of the maximal 
KCl (80 mmol/liter)-induced contraction using phenylephrine. All experi-
ments were performed in the presence of 10 µmol/liter diclofenac, and re-
laxations  are  denoted  in  the  figures  as  the  percentage  of  the  maximal 
relaxation obtained by 10 µmol/liter sodium nitroprusside.
Statistical analysis. Data are expressed as means ± SEM. Statistical evalua-
tion was performed on the absolute values or on log-transformed data with 
the Student’s t test for unpaired data, one-way analysis of variance (ANOVA) 
followed by a Bonferroni t test, or ANOVA for repeated measures where 
appropriate. P < 0.05 was considered statistically significant.
Online supplemental material. Fig. S1 shows the Ang II–induced pro-
duction of H2O2 in cultured endothelial cells. Fig. S2 shows the endogenous 
production of H2O2 in carotid arteries kept in tissue culture. Online supple-
mental  material  is  available  at  http://www.jem.org/cgi/content/full/jem 
.20090449/DC1.
Animal experiments. Animal experiments were approved by the Regier-
ungspräsidium Darmstadt (F18/14). 6–9-wk-old male C57/b6 mice were 
obtained from Charles River. Male C57/b6 eNOS/ mice (provided by A. 
Gödecke, Heinrich-Heine-Universität, Düsseldorf, Germany) and Nox2y/ 
mice (The Jackson Laboratory) were bred at the animal facilities at Frankfurt 
University. In a subgroup of 16 wild-type, 16 Nox2y/, and 16 Nox2y/+ 
mice, osmotic mini-pumps (ALZET) delivering either vehicle (0.9% NaCl; 
8 animals per group) or [5val]–Ang II (1 mg/kg/day for 3 wk; 8 animals per 
group) were implanted subcutaneously under isoflurane anesthesia.
Adenoviruses encoding GFP, wild-type eNOS, Y657F eNOS, or DN 
PYK2 were generated and delivered to the endothelial layer of carotid ar-
teries from wild-type or eNOS/ mice, as described previously (Dixit   
et al., 2005; Fisslthaler et al., 2008). In brief, mice were euthanized with 
isoflurane, and the aortic arches and carotid arteries were prepared free of 
adhering tissue but left in situ. Each vessel was filled with MCDB 131 con-
taining 2% FCS (FBS GOLD; PAA) and viral particles (1.5 × 108 PFU/ml). The 
vessel was slightly pressurized, ligated at both ends, and incubated in me-
dium containing 2% FCS for 4 h. After the initial incubation, the ligatures 
were removed and the vessel was maintained in tissue culture for an addi-
tional 40–44 h.
Figure 6.  Chronic Ang II infusion induces Tyr657 phosphorylation of eNOS in wild-type but not in Nox2y/ mice. (A–D) Wild-type mice 
(A and B), and Nox2y/ mice (y/) or the corresponding wild-type littermates (y/+; C and D) were treated with vehicle (Sol) or 1 mg/kg/day Ang II for 3 
wk, after which endothelium-dependent relaxation in response to ACh (A and C) and eNOS Tyr657 phosphorylation (B and D) were assessed in aortic 
segments. The graphs summarize data from eight mice per group stratified over two (A and B) or four (C and D) independent experiments; immuno-
precipitations (IP) were performed on lysates from two pooled aortae. Data are expressed as means ± SEM. *, P < 0.05; and ***, P < 0.001 versus the 
corresponding vehicle (Sol) control. WB, Western blotting.2896 eNOS phosphorylation in endothelial dysfunction | Loot et al.
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